The antltumour antibiotic actinomycin D normally binds to DNA by intercalation at sequences containing the CpG step, but In the presence of daunomycin It has been reported to Interact with poly(dA-dT). This observation has neither been confirmed nor explained. Here we have used a photoreactlve 7-azido derivative of actinomycin to study the effect of daunomycin on its binding to three DNA fragments. Daunomycin did indeed alter the binding of actinomycin to the DNA, such that the antibiotic was displaced from Its primary GpC sites onto secondary sites in the DNA, though not to AT regions especially. These findings suggest a possible scientific explanation for the Increased toxldty seen during combination chemotherapy with these two drugs
We have used footprinting techniques on a wide range of natural and synthetic footprinting substrate...
AbstractDNase I footprinting has been used to examine the sequence selective binding of ditrisarubic...
NoThe design and synthesis of a potentially more therapeutically-viable azinomycin analogue 4 based ...
AbstractWe have analyzed the specificity of the actinomycin D—DNA interaction. The ‘footprint’ metho...
Although daunomycin and adriamycin are considered effective antitumor drugs and have been used in th...
A modified actinomycin D was prepared with a hydroxyl group that replaced the amino group at the chr...
Morpholino and cyanomorpholino derivatives of the anthracycline antitumor antibiotics, Adriamycin an...
Actinomycin D in low concentrations was suggested to inhibit ribosomal RNA (rRNA) transcription via ...
Cancer is a major health issue adsorbing the attention of a biomedical research. To fight this disea...
Actinomycin, echinomycin and [N-Me Cys3 N-Me Cys7] TANDEM bind to double stranded DNA by a sequence ...
THERE have been several different approaches to the stereochemistry of the interaction of actinomyci...
AbstractThe interaction of daunomycin with B and Z helices of a self-complementary DNA fragment d(CG...
AbstractThe DNA-sequence specificity of daunomycin was investigated by DNase I footprinting and an E...
complexes have yielded many insights into how small molecules affect the structure of DNA (Berman an...
The anthracycline drug daunomycin exhibits complex mechanisms of anticancer action, which are not we...
We have used footprinting techniques on a wide range of natural and synthetic footprinting substrate...
AbstractDNase I footprinting has been used to examine the sequence selective binding of ditrisarubic...
NoThe design and synthesis of a potentially more therapeutically-viable azinomycin analogue 4 based ...
AbstractWe have analyzed the specificity of the actinomycin D—DNA interaction. The ‘footprint’ metho...
Although daunomycin and adriamycin are considered effective antitumor drugs and have been used in th...
A modified actinomycin D was prepared with a hydroxyl group that replaced the amino group at the chr...
Morpholino and cyanomorpholino derivatives of the anthracycline antitumor antibiotics, Adriamycin an...
Actinomycin D in low concentrations was suggested to inhibit ribosomal RNA (rRNA) transcription via ...
Cancer is a major health issue adsorbing the attention of a biomedical research. To fight this disea...
Actinomycin, echinomycin and [N-Me Cys3 N-Me Cys7] TANDEM bind to double stranded DNA by a sequence ...
THERE have been several different approaches to the stereochemistry of the interaction of actinomyci...
AbstractThe interaction of daunomycin with B and Z helices of a self-complementary DNA fragment d(CG...
AbstractThe DNA-sequence specificity of daunomycin was investigated by DNase I footprinting and an E...
complexes have yielded many insights into how small molecules affect the structure of DNA (Berman an...
The anthracycline drug daunomycin exhibits complex mechanisms of anticancer action, which are not we...
We have used footprinting techniques on a wide range of natural and synthetic footprinting substrate...
AbstractDNase I footprinting has been used to examine the sequence selective binding of ditrisarubic...
NoThe design and synthesis of a potentially more therapeutically-viable azinomycin analogue 4 based ...